• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管扩张症的结核后表型特征:一项真实世界观察性研究。

Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study.

机构信息

Department of Respiratory and Critical Care Medicine, 26674Changi General Hospital, Singapore, Singapore.

Respiratory Medicine, Raffles Specialist Centre, Singapore, Singapore.

出版信息

Chron Respir Dis. 2022 Jan-Dec;19:14799731221098714. doi: 10.1177/14799731221098714.

DOI:10.1177/14799731221098714
PMID:35471849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9052827/
Abstract

OBJECTIVE

Bronchiectasis is a heterogeneous disease with distinct phenotypes. The post-tuberculosis (post-TB) bronchiectasis phenotype is prevalent in many countries but is under-studied. Our aim was to identify distinct phenotypic characteristics of post-TB bronchiectasis.

METHODS

We recruited adults admitted between Jan 2010-Oct 2017 at Changi General Hospital, Singapore for bronchiectasis exacerbation. We collected demographics, symptoms, lung function, microbiology and FACED scores. Participants were followed-up until the next hospitalized exacerbation or end of study, whichever was sooner. Participants diagnosed by their attending respiratory specialist to have post-TB bronchiectasis were compared to those with bronchiectasis from other aetiologies.

RESULTS

148 participants were included with mean±standard deviation age 63 ± 9 years; 46 (31.1%) had post-TB bronchiectasis and 102 (68.9%) other aetiologies. Compared to other aetiologies, participants with post-TB bronchiectasis had significantly lower body mass index (BMI), more frequent presentation with haemoptysis, lower forced expiratory volume in one second (FEV), more frequent isolation of nontuberculous mycobacteria (NTM), and higher FACED scores indicating greater disease severity. Over a median follow-up of 21 months, post-TB bronchiectasis was associated with shorter time to next hospitalized exacerbation (49 vs 76 months, Log-Rank = .01).

CONCLUSION

Post-TB bronchiectasis is a distinct entity with higher rates of haemoptysis and NTM isolation, more frequent exacerbations, and greater disease severity.

摘要

目的

支气管扩张症是一种具有不同表型的异质性疾病。肺结核后(post-TB)支气管扩张症表型在许多国家都很普遍,但研究不足。我们的目的是确定肺结核后支气管扩张症的不同表型特征。

方法

我们招募了 2010 年 1 月至 2017 年 10 月期间在新加坡樟宜综合医院因支气管扩张症加重而住院的成年人。我们收集了人口统计学、症状、肺功能、微生物学和 FACED 评分。参与者在随访期间直到下一次住院加重或研究结束(以先发生者为准)。由呼吸专科医生诊断为肺结核后支气管扩张症的患者与其他病因引起的支气管扩张症患者进行比较。

结果

共纳入 148 名参与者,平均年龄±标准差为 63 ± 9 岁;46 名(31.1%)为肺结核后支气管扩张症,102 名(68.9%)为其他病因。与其他病因相比,肺结核后支气管扩张症患者的体重指数(BMI)明显较低,更频繁地出现咯血,第一秒用力呼气量(FEV)较低,非结核分枝杆菌(NTM)分离更为频繁,FACED 评分更高,表明疾病严重程度更高。在中位数为 21 个月的随访期间,肺结核后支气管扩张症患者下一次住院加重的时间更短(49 个月 vs 76 个月,对数秩检验=.01)。

结论

肺结核后支气管扩张症是一种独特的实体,具有更高的咯血和 NTM 分离率、更频繁的加重和更高的疾病严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/9052827/9779d0adfb13/10.1177_14799731221098714-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/9052827/49e0146689b2/10.1177_14799731221098714-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/9052827/9779d0adfb13/10.1177_14799731221098714-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/9052827/49e0146689b2/10.1177_14799731221098714-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/9052827/9779d0adfb13/10.1177_14799731221098714-fig2.jpg

相似文献

1
Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study.支气管扩张症的结核后表型特征:一项真实世界观察性研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221098714. doi: 10.1177/14799731221098714.
2
Performance of Multidimensional Severity Scoring Systems in Patients with Post-Tuberculosis Bronchiectasis.多维严重程度评分系统在肺结核后支气管扩张患者中的表现
Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2157-2165. doi: 10.2147/COPD.S261797. eCollection 2020.
3
Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.泰国慢性阻塞性肺疾病(COPD)患者支气管扩张的存在与急性加重之间的关系。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:761-769. doi: 10.2147/COPD.S139776. eCollection 2018.
4
Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.中国南京地区非结核分枝杆菌肺病的特征。
BMC Infect Dis. 2019 Sep 2;19(1):764. doi: 10.1186/s12879-019-4412-6.
5
Haemoptysis due to chronic tuberculosis vs. bronchiectasis: comparison of long-term outcome of arterial embolisation.慢性肺结核与支气管扩张所致咯血:动脉栓塞长期疗效比较
Int J Tuberc Lung Dis. 2007 Jul;11(7):781-7.
6
Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016.2012-2016 年新加坡非结核分枝杆菌病的临床和微生物学特征,重点是肺部疾病。
BMC Infect Dis. 2019 May 17;19(1):436. doi: 10.1186/s12879-019-3909-3.
7
Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.加纳艾滋病毒感染者中的结核病和非结核分枝杆菌
Trop Med Int Health. 2016 Sep;21(9):1181-90. doi: 10.1111/tmi.12749. Epub 2016 Jul 25.
8
Characteristics and comparison of rapidly growing and slowly growing nontuberculous mycobacterial pulmonary disease.快速生长和缓慢生长的非结核分枝杆菌肺病的特征及比较
Int J Mycobacteriol. 2023 Jul-Sep;12(3):324-331. doi: 10.4103/ijmy.ijmy_145_23.
9
Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore.在亚洲环境中分析非结核分枝杆菌:新加坡住院患者的特征和临床结局。
BMC Pulm Med. 2018 May 22;18(1):85. doi: 10.1186/s12890-018-0637-1.
10
Association between bronchiectasis exacerbations and longitudinal changes in FEV in patients from the US bronchiectasis and NTM research registry.美国支气管扩张症和非结核分枝杆菌研究注册中心的患者中支气管扩张症加重与 FEV 纵向变化的相关性。
Respir Med. 2024 Jul;228:107660. doi: 10.1016/j.rmed.2024.107660. Epub 2024 May 9.

引用本文的文献

1
Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease.结核病相关慢性阻塞性肺疾病的发病率及危险因素
Int J Chron Obstruct Pulmon Dis. 2025 Jun 26;20:2091-2102. doi: 10.2147/COPD.S523732. eCollection 2025.
2
Pulmonary Nontuberculous Mycobacteria Infection in Bronchiectasis: A Narrative Review of Current Status and Future.支气管扩张症中的非结核分枝杆菌肺部感染:现状与未来的叙述性综述
Health Sci Rep. 2025 Apr 23;8(4):e70749. doi: 10.1002/hsr2.70749. eCollection 2025 Apr.
3
Neutrophilic inflammation in bronchiectasis.

本文引用的文献

1
Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore.新加坡需住院治疗的支气管扩张症的流行病学及经济负担
ERJ Open Res. 2021 Oct 25;7(4). doi: 10.1183/23120541.00334-2021. eCollection 2021 Oct.
2
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge.肺结核后肺部疾病:一个被低估的全球性挑战的临床综述。
Respiration. 2021;100(8):751-763. doi: 10.1159/000512531. Epub 2021 Jan 5.
3
Performance of Multidimensional Severity Scoring Systems in Patients with Post-Tuberculosis Bronchiectasis.
支气管扩张症中的中性粒细胞性炎症。
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0179-2024. Print 2025 Apr.
4
Epidemiology of bronchiectasis.支气管扩张症的流行病学。
Eur Respir Rev. 2024 Oct 9;33(174). doi: 10.1183/16000617.0091-2024. Print 2024 Oct.
5
A systematic literature review of the clinical and socioeconomic burden of bronchiectasis.支气管扩张症的临床和社会经济学负担的系统文献回顾。
Eur Respir Rev. 2024 Sep 4;33(173). doi: 10.1183/16000617.0049-2024. Print 2024 Jul.
6
Non-cystic fibrosis bronchiectasis: A single-centre retrospective study in Johannesburg, South Africa.非囊性纤维化支气管扩张症:南非约翰内斯堡的一项单中心回顾性研究。
Afr J Thorac Crit Care Med. 2023 Nov 27;29(4):e1017. doi: 10.7196/AJTCCM.2023.v29i4.1017. eCollection 2023.
7
Long term management of people with post-tuberculosis lung disease.肺结核病后患者的长期管理。
Korean J Intern Med. 2024 Jan;39(1):7-24. doi: 10.3904/kjim.2023.395. Epub 2024 Jan 1.
8
Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea.咯血作为韩国支气管扩张症相关住院治疗的首发表现。
J Thorac Dis. 2023 Jul 31;15(7):3636-3645. doi: 10.21037/jtd-22-1541. Epub 2023 Jun 25.
9
Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.铜绿假单胞菌分离是特发性支气管扩张症患者支气管动脉栓塞后复发性咯血的重要预测指标:一项多中心队列研究。
Respir Res. 2023 Mar 18;24(1):84. doi: 10.1186/s12931-023-02391-9.
10
Profile of patients with post-tuberculosis bronchiectasis in a tertiary care hospital in Brazil.巴西一家三级护理医院中肺结核后支气管扩张患者的概况。
J Clin Tuberc Other Mycobact Dis. 2022 Nov 13;29:100339. doi: 10.1016/j.jctube.2022.100339. eCollection 2022 Dec.
多维严重程度评分系统在肺结核后支气管扩张患者中的表现
Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2157-2165. doi: 10.2147/COPD.S261797. eCollection 2020.
4
Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016.台湾支气管扩张症患者的病因和特征:2002 年至 2016 年的队列研究。
BMC Pulm Med. 2020 Feb 18;20(1):45. doi: 10.1186/s12890-020-1080-7.
5
Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.印度支气管扩张症:来自欧洲多国支气管扩张症审核和研究协作组织(EMBARC)和印度呼吸研究网络注册研究的结果。
Lancet Glob Health. 2019 Sep;7(9):e1269-e1279. doi: 10.1016/S2214-109X(19)30327-4.
6
The significant global economic burden of bronchiectasis: a pending matter.支气管扩张症的重大全球经济负担:一个悬而未决的问题。
Eur Respir J. 2019 Feb 28;53(2). doi: 10.1183/13993003.02392-2018. Print 2019 Feb.
7
British Thoracic Society Guideline for bronchiectasis in adults.英国胸科学会成人支气管扩张指南。
Thorax. 2019 Jan;74(Suppl 1):1-69. doi: 10.1136/thoraxjnl-2018-212463.
8
Bronchiectasis.支气管扩张症。
Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3.
9
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.支气管扩张症的研究进展:表型分型、遗传学、微生物组学和疾病异质性。
Lancet. 2018 Sep 8;392(10150):880-890. doi: 10.1016/S0140-6736(18)31767-7.
10
International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review.关于肺结核后慢性肺部疾病的国际研究与指南:一项系统的范围综述
BMJ Glob Health. 2018 Jul 23;3(4):e000745. doi: 10.1136/bmjgh-2018-000745. eCollection 2018.